Additionally, the study found no presence of urinary stones
Liraglutide, semaglutide and tirzepatide are incretin-based therapies currently approved by FDA for the management of obesity, while triple GIPR/GCGR/GLP-1R agonist retatrutide (LY3437943), the cagrilintide/semaglutide (CagriSema) 2.4 mg combination, high-dose oral semaglutide, and oral orforglipron are in advanced stages of development
l-carnitine treatment has also shown potential in the treatment of other conditions like myalgic encephalomyelitis (ME)/chronic fatigue syndrome (CFS) [102], neurodegenerative diseases [103], and diabetes [49,104,105]
Researchers often prefer Mod GRF for more controlled, pulse-based study protocols
LDL-C, low-density lipoprotein cholesterol
Another study showed that a multiple micronutrient supplement improved hemoglobin synthesis as well as an iron supplement, despite containing less iron, in a population of pregnant women (Allen 2009)